Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03IVG
|
|||
Former ID |
DIB020045
|
|||
Drug Name |
imiloxan
|
|||
Synonyms |
RS-21361; GNF-Pf-2156
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C14H16N2O2
|
|||
Canonical SMILES |
CCN1C=CN=C1CC2COC3=CC=CC=C3O2
|
|||
InChI |
1S/C14H16N2O2/c1-2-16-8-7-15-14(16)9-11-10-17-12-5-3-4-6-13(12)18-11/h3-8,11H,2,9-10H2,1H3
|
|||
InChIKey |
UXABARREKCJULM-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 81167-16-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
7734666, 7979597, 10243413, 12012640, 15019917, 26752007, 29311505, 47500596, 47647598, 48244473, 50104679, 57344592, 79391242, 85209112, 85788122, 90341379, 103073023, 103084716, 103411089, 104171179, 104380223, 117603563, 124749929, 124880475, 124880476, 126437710, 129432694, 131332122, 135089115, 136351334, 136368380, 137006275, 143259520, 144203726, 170466588, 178100464, 179293618, 184591510, 223682208, 224859049, 227042536, 249980832
|
|||
ChEBI ID |
CHEBI:91522
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor alpha-2B (ADRA2B) | Target Info | Antagonist | [2] |
KEGG Pathway | cGMP-PKG signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Panther Pathway | Alpha adrenergic receptor signaling pathway | |||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Reactome | Adrenoceptors | |||
Adrenaline signalling through Alpha-2 adrenergic receptor | ||||
G alpha (i) signalling events | ||||
G alpha (z) signalling events | ||||
WikiPathways | Monoamine GPCRs | |||
GPCRs, Class A Rhodopsin-like | ||||
Platelet Aggregation (Plug Formation) | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3470). | |||
REF 2 | Assessment of imiloxan as a selective alpha 2B-adrenoceptor antagonist. Br J Pharmacol. 1990 Mar;99(3):560-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.